Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitus.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4405925)

Published in Indian J Med Res on January 01, 2015

Authors

Seema Garg1, S V Madhu, Shilpa Suneja

Author Affiliations

1: Department of Biochemistr, University College of Medical Sciences & Guru Teg Bahadur Hospital, (University of Delhi), Delhi, India.

Articles cited by this

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79

Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34

Enzymatic determination of total serum cholesterol. Clin Chem (1974) 20.65

Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res (1970) 9.50

Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21

Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem (1982) 4.93

An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med (2006) 4.23

An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst (1972) 3.47

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc (2007) 3.12

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem J (1999) 1.92

The current state of diabetes mellitus in India. Australas Med J (2014) 1.74

Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol (1999) 1.71

Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis (2000) 1.58

The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol (2002) 1.54

Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation (2002) 1.43

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis (1992) 1.40

Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler Suppl (2002) 1.34

Platelet-activating factor acetylhydrolases in health and disease. Biochim Biophys Acta (2000) 1.15

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study. Atherosclerosis (2009) 1.11

Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes. Diabetes (2010) 1.06

Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem (1996) 0.93

Lipoprotein-associated phospholipase A(2) mass and activity and risk of cardiovascular disease in a population with high prevalences of obesity and diabetes: the Strong Heart Study. Diabetes Care (2012) 0.91

All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase. Arterioscler Thromb Vasc Biol (1999) 0.89

Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study. Diabetologia (2010) 0.89

Effect of improving glycemic control in patients with type 2 diabetes mellitus on low-density lipoprotein size, electronegative low-density lipoprotein and lipoprotein-associated phospholipase A2 distribution. Am J Cardiol (2012) 0.88

Phospholipase A2 inhibitors. Curr Opin Lipidol (2009) 0.86

Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus. J Lipid Res (2003) 0.86

Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment. J Lipid Mediat Cell Signal (1997) 0.85

Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity: a placebo-controlled trial in patients with type 2 diabetes. J Clin Endocrinol Metab (2004) 0.81

Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients. Diabetes Metab J (2011) 0.80

Platelet-activating factor acetylhydrolase (PAF-AH) activity in patients with type 1 diabetes mellitus. Arq Bras Cardiol (2007) 0.80

Articles by these authors

Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia (2011) 5.62

300,000 IU or 600,000 IU of oral vitamin D3 for treatment of nutritional rickets: a randomized controlled trial. Indian Pediatr (2014) 2.08

Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients. J Assoc Physicians India (2004) 1.51

Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease. J Assoc Physicians India (2010) 1.49

Plasma renin activity in diabetics with and without microangiopathy. J Assoc Physicians India (1991) 1.38

The problem of emerging chloramphenicol resistance in typhoid fever--a preliminary report. J Assoc Physicians India (1991) 1.30

A preliminary report on the role of yoga asanas on oxidative stress in non-insulin dependent diabetes mellitus. Indian J Clin Biochem (2001) 1.14

Influence of pranayamas and yoga-asanas on serum insulin, blood glucose and lipid profile in type 2 diabetes. Indian J Clin Biochem (2008) 1.13

Effect of Yoga asanas on nerve conduction in type 2 diabetes. Indian J Physiol Pharmacol (2002) 1.10

Study of yoga asanas in assessment of pulmonary function in NIDDM patients. Indian J Physiol Pharmacol (2002) 1.06

Fluorotoxic metabolic bone disease: an osteo-renal syndrome caused by excess fluoride ingestion in the tropics. Bone (2006) 1.00

Functional status of auditory pathways in hypothyroidism: evoked potential study. Indian J Physiol Pharmacol (2007) 0.99

Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). Postgrad Med J (2012) 0.98

Association analysis of TNFRSF1B polymorphisms with type 2 diabetes and its related traits in North India. Genomic Med (2009) 0.93

Correlates of Type 2 diabetes mellitus in children, adolescents and young adults in north India: a multisite collaborative case-control study. Diabet Med (2006) 0.93

Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians. Atherosclerosis (2011) 0.92

Blood pressure trends, plasma insulin levels and risk factors in rural and urban elderly populations of north India. Coron Artery Dis (1997) 0.87

The dirty dozen of diabetes. Indian J Endocrinol Metab (2013) 0.87

Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy. QJM (2008) 0.86

Cognitive status in hypothyroid female patients: event-related evoked potential study. Neuroendocrinology (2008) 0.86

Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro. Mol Cell Biochem (2011) 0.86

Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress. Indian J Biochem Biophys (2007) 0.85

Endocrine stress responses and risk of type 2 diabetes mellitus. Stress (2015) 0.80

Colonic myoelectrical activity in irritable bowel syndrome before and after treatment. Indian J Gastroenterol (1988) 0.79

Effect of thyroxine therapy on autonomic status in hypothyroid patients. Indian J Physiol Pharmacol (2010) 0.79

Diet and lifestyle guidelines and desirable levels of risk factors for the prevention of diabetes and its vascular complications in Indians: a scientific statement of The International College of Nutrition. Indian Consensus Group for the Prevention of Diabetes. J Cardiovasc Risk (1997) 0.78

The association between insulin and low-density lipoprotein receptors. Diab Vasc Dis Res (2012) 0.78

Hypogonadism in male Leprosy patients--a study from rural Uttar pradesh. J Commun Dis (2005) 0.78

Common variants of SLAMF1 and ITLN1 on 1q21 are associated with type 2 diabetes in Indian population. J Hum Genet (2012) 0.77

Endothelial dysfunction and diabetes. J Assoc Physicians India (2010) 0.76

Delayed auditory conduction in diabetes: is metformin-induced vitamin B12 deficiency responsible? Funct Neurol (2016) 0.75

Phenytoin induced severe disabling osteomalacia in a young male with seizure disorder. J Assoc Physicians India (2008) 0.75

Socio-demographic profile of leprosy patients in two districts of western Uttar Pradesh. J Commun Dis (2007) 0.75

Enalapril monotherapy in essential hypertension. J Assoc Physicians India (1992) 0.75

Prevalence and pattern of use of indigenous medicines in diabetic patients attending a tertiary care centre. J Indian Med Assoc (2011) 0.75

Malignant peritoneal mesothelioma: a case report. J Indian Med Assoc (1996) 0.75

Shy-Drager syndrome. J Indian Med Assoc (1993) 0.75

Subgaleal haematoma following hair pulling. J Assoc Physicians India (1990) 0.75

Filarial pleural effusion with constrictive pericarditis. Indian J Chest Dis Allied Sci (1995) 0.75

Vitamin D Supplementation for Treatment and Prevention of Pneumonia in Under-five Children: A Randomized Double-blind Placebo Controlled Trial. Indian Pediatr (2016) 0.75

Utility of continuous glucose monitoring system in clinical practice--a report of two cases. J Indian Med Assoc (2012) 0.75

Pancytopenia--a rare presentation of miliary tuberculosis. J Assoc Physicians India (1993) 0.75

Sunlight Exposure and Vitamin D Status in Breastfed Infants. Indian Pediatr (2016) 0.75

Kartagener's syndrome. J Assoc Physicians India (1987) 0.75

Atypical case of cerebral venous thrombosis diagnosed by MRI. J Assoc Physicians India (1995) 0.75

Prevalence of diabetes in hotel employees. J Med Assoc Thai (1987) 0.75

Reiter's disease with uncommon presentation. J Assoc Physicians India (1993) 0.75